77 related articles for article (PubMed ID: 6013064)
1. [Pharmacological study of p-butoxyphenylacethydroxamic acid (CP 1044 J3). II. Toxicological research].
Lambelin G; Buu-Hoi NP; Mees G; Thiriaux J; Huriaux M
Med Pharmacol Exp Int J Exp Med; 1966; 15(6):545-54. PubMed ID: 6013064
[No Abstract] [Full Text] [Related]
2. Teratological studies of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in rats and rabbits.
Roba J; Lambelin G; Buu-Hoï NP
Arzneimittelforschung; 1970 Apr; 20(4):565-9. PubMed ID: 5467822
[No Abstract] [Full Text] [Related]
3. Further study of the anti-inflammatory mode of action of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in the rat.
Lambelin G; Roba J; Parmentier R; Buu-Hoï NP
Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):241-53. PubMed ID: 5357009
[No Abstract] [Full Text] [Related]
4. [Chemical constitution and teratogenic effect in rats. I. Carbonic acid amides, carbonic acid hydrazides and hydroxamic acids].
von Kreybig T; Preussmann R; Schmidt W
Arzneimittelforschung; 1968 Jun; 18(6):645-57. PubMed ID: 5755800
[No Abstract] [Full Text] [Related]
5. [A morphogenic study of postaxial synactyly induced in the rat by hadacidin. II. The limb buds in 12- to 14 day embryos].
Milaire J
Arch Biol (Liege); 1971; 82(3):253-322. PubMed ID: 4333477
[No Abstract] [Full Text] [Related]
6. [Pharmacological studies on decanohydroxamic acid. 3. General pharmacological action. (2)].
Kitagawa H; Yoshida S; Abe M; Ohno F
Yakugaku Zasshi; 1965 Oct; 85(10):912-6. PubMed ID: 5893656
[No Abstract] [Full Text] [Related]
7. [Teratogenic effect of hadacin on the rat].
Roux C; Horvath C
C R Seances Soc Biol Fil; 1970; 164(10):1919-22. PubMed ID: 4254404
[No Abstract] [Full Text] [Related]
8. The effects of hydroxyurea and related compounds on the rat fetus.
Chaube S; Murphy ML
Cancer Res; 1966 Jul; 26(7):1448-57. PubMed ID: 5911587
[No Abstract] [Full Text] [Related]
9. Biodegradations of the hydroxamic acid group of p-n-butoxyphenylacethydroxamic acid (bufexamac) in various animal species.
Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP
Xenobiotica; 1971; 1(4):567-8. PubMed ID: 5164808
[No Abstract] [Full Text] [Related]
10. [P-butoxyphenylacethydroxamic acid in analgesic and anti-inflammatory therapy].
Rosoux E
Brux Med; 1969 Jul; 49(7):467-9. PubMed ID: 5402954
[No Abstract] [Full Text] [Related]
11. [Pharmacological studies on decanohydroxamic acid. V. Percutaneous absorption, distribution on rats and percutaneous subacute toxicity on rabbits].
Kitagawa H; Yoshida S; Abe M; Fukuda Y
Yakugaku Zasshi; 1965 Nov; 85(11):1017-21. PubMed ID: 5893831
[No Abstract] [Full Text] [Related]
12. Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.
Wise LD; Turner KJ; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):57-68. PubMed ID: 17294457
[TBL] [Abstract][Full Text] [Related]
13. [Distribution, metabolism and excretion of a new anti-inflammatory agent: p-butoxyphenyl-acethydroxamic acid (CP 1044 J3)].
Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP; Thiriaux J
Biochem Pharmacol; 1966 Oct; 15(10):1563-75. PubMed ID: 5971809
[No Abstract] [Full Text] [Related]
14. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
Butler LM; Agus DB; Scher HI; Higgins B; Rose A; Cordon-Cardo C; Thaler HT; Rifkind RA; Marks PA; Richon VM
Cancer Res; 2000 Sep; 60(18):5165-70. PubMed ID: 11016644
[TBL] [Abstract][Full Text] [Related]
16. Separation and identification of urinary metabolites of 14C-p-n-butoxyphenylacethydroxamic acid in man.
Roncucci R; Simon MJ; Lambelin G; Thiriaux J; Buu-Hoi NP
Biochem Pharmacol; 1968 Feb; 17(2):187-94. PubMed ID: 5647045
[No Abstract] [Full Text] [Related]
17. Assessment of female and male fertility in Sprague-Dawley rats administered vorinostat, a histone deacetylase inhibitor.
Wise LD; Spence S; Saldutti LP; Kerr JS
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):19-26. PubMed ID: 18092367
[TBL] [Abstract][Full Text] [Related]
18. [Chronic toxicity of bufexamac in the rat and monkey].
Lambelin G; Roba J; Roncucci R
Boll Chim Farm; 1974 Aug; 113(8):437-54. PubMed ID: 4215440
[No Abstract] [Full Text] [Related]
19. Elimination of 4-n-butoxyphenylacethydroxamic acid (bufexamac) in man.
Boreham DR; Cummings AJ; Della D; Martin BK
J Pharm Sci; 1972 Feb; 61(2):164-8. PubMed ID: 4551072
[No Abstract] [Full Text] [Related]
20. Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate.
Dahl GA; Miller EC; Miller JA
Cancer Res; 1980 Apr; 40(4):1194-203. PubMed ID: 7357549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
